| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRG3 ANO9 STIM2 GRID1 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 SCN4A CACNA2D3 GABRA3 KCNH5 | 1.82e-06 | 459 | 112 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | gated channel activity | GABRG3 ANO9 GRID1 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 CACNA2D3 GABRA3 KCNH5 | 2.84e-06 | 334 | 112 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | channel activity | GABRG3 ANO9 STIM2 GRID1 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 SCN4A CACNA2D3 GABRA3 KCNH5 | 7.83e-06 | 525 | 112 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRG3 ANO9 STIM2 GRID1 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 SCN4A CACNA2D3 GABRA3 KCNH5 | 7.99e-06 | 526 | 112 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | calcium channel activity | 8.23e-06 | 129 | 112 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.33e-05 | 193 | 112 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.54e-05 | 197 | 112 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.68e-05 | 57 | 112 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.17e-05 | 60 | 112 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.30e-05 | 151 | 112 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.63e-05 | 31 | 112 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.21e-05 | 65 | 112 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.21e-05 | 65 | 112 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 6.41e-05 | 75 | 112 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 7.27e-05 | 77 | 112 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG3 ABCC1 ANO9 STIM2 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 COX5A SCN4A CACNA2D3 GABRA3 KCNH5 | 8.78e-05 | 758 | 112 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.16e-04 | 85 | 112 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | STIM2 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 SCN4A CACNA2D3 KCNH5 | 1.36e-04 | 343 | 112 | 9 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRG3 ANO9 STIM2 GRID1 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 COX5A SCN4A CACNA2D3 GABRA3 KCNH5 | 1.41e-04 | 793 | 112 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | RNA cap binding | 2.12e-04 | 21 | 112 | 3 | GO:0000339 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.50e-04 | 100 | 112 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | calcium ion binding | UNC13B EFCAB5 PRRG2 DCHS2 STIM2 RCN2 DNAH7 RYR3 ITPR3 NKD1 MACF1 CDH3 CDH6 | 2.92e-04 | 749 | 112 | 13 | GO:0005509 |
| GeneOntologyMolecularFunction | pheromone binding | 3.08e-04 | 5 | 112 | 2 | GO:0005550 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 3.08e-04 | 5 | 112 | 2 | GO:0005025 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 4.55e-04 | 27 | 112 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | BMP receptor activity | 8.54e-04 | 8 | 112 | 2 | GO:0098821 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 8.54e-04 | 8 | 112 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 8.54e-04 | 8 | 112 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | STIM2 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 SCN4A CACNA2D3 KCNH5 | 1.23e-03 | 465 | 112 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.66e-03 | 11 | 112 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | transporter activity | GABRG3 ABCC1 ANO9 STIM2 GRID1 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 IGF1R COX5A SCN4A CACNA2D3 GABRA3 KCNH5 | 2.22e-03 | 1289 | 112 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 2.34e-03 | 13 | 112 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRG3 ABCC1 ANO9 STIM2 GRID1 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 COX5A SCN4A CACNA2D3 GABRA3 KCNH5 | 2.45e-03 | 1180 | 112 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 2.72e-03 | 14 | 112 | 2 | GO:0000340 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.78e-03 | 50 | 112 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | STIM2 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 COX5A SCN4A CACNA2D3 KCNH5 | 2.78e-03 | 627 | 112 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.64e-03 | 182 | 112 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.81e-03 | 184 | 112 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 4.01e-03 | 17 | 112 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | STIM2 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 COX5A SCN4A CACNA2D3 KCNH5 | 4.17e-03 | 664 | 112 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 4.50e-03 | 18 | 112 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 4.50e-03 | 18 | 112 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.50e-03 | 18 | 112 | 2 | GO:0008569 | |
| Domain | KRAB | ZNF132 ZNF560 POGK ZNF862 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 ZNF75D | 2.10e-07 | 358 | 111 | 13 | PS50805 |
| Domain | KRAB | ZNF132 ZNF560 POGK ZNF862 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 ZNF75D | 2.10e-07 | 358 | 111 | 13 | PF01352 |
| Domain | KRAB | ZNF132 ZNF560 POGK ZNF862 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 ZNF75D | 2.97e-07 | 369 | 111 | 13 | SM00349 |
| Domain | KRAB | ZNF132 ZNF560 POGK ZNF862 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 ZNF75D | 3.06e-07 | 370 | 111 | 13 | IPR001909 |
| Domain | DM15 | 3.50e-05 | 2 | 111 | 2 | SM00684 | |
| Domain | DM15 | 3.50e-05 | 2 | 111 | 2 | IPR006607 | |
| Domain | von_Ebner_gland | 1.05e-04 | 3 | 111 | 2 | IPR002450 | |
| Domain | Pkinase_Tyr | 1.21e-04 | 129 | 111 | 6 | PF07714 | |
| Domain | Lig_chan-Glu_bd | 1.56e-04 | 18 | 111 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 1.56e-04 | 18 | 111 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.56e-04 | 18 | 111 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 1.56e-04 | 18 | 111 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 1.56e-04 | 18 | 111 | 3 | IPR001508 | |
| Domain | Lig_chan | 1.56e-04 | 18 | 111 | 3 | PF00060 | |
| Domain | PBPe | 1.56e-04 | 18 | 111 | 3 | SM00079 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.75e-04 | 138 | 111 | 6 | IPR001245 | |
| Domain | VDCC_a2/dsu | 2.08e-04 | 4 | 111 | 2 | IPR013680 | |
| Domain | VGCC_alpha2 | 2.08e-04 | 4 | 111 | 2 | PF08473 | |
| Domain | VWA_N | 3.46e-04 | 5 | 111 | 2 | IPR013608 | |
| Domain | VWA_N | 3.46e-04 | 5 | 111 | 2 | PF08399 | |
| Domain | RIH_assoc-dom | 5.17e-04 | 6 | 111 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 5.17e-04 | 6 | 111 | 2 | PF08709 | |
| Domain | RIH_assoc | 5.17e-04 | 6 | 111 | 2 | PF08454 | |
| Domain | RIH_dom | 5.17e-04 | 6 | 111 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.17e-04 | 6 | 111 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 5.17e-04 | 6 | 111 | 2 | IPR015925 | |
| Domain | - | 5.17e-04 | 6 | 111 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 5.17e-04 | 6 | 111 | 2 | PF01365 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF132 ZNF560 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 JAZF1 ZNF75D ZC3H7B | 6.91e-04 | 775 | 111 | 13 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF132 ZNF560 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 JAZF1 ZNF75D ZC3H7B | 7.08e-04 | 777 | 111 | 13 | PS00028 |
| Domain | GS_dom | 7.21e-04 | 7 | 111 | 2 | IPR003605 | |
| Domain | LA | 7.21e-04 | 7 | 111 | 2 | SM00715 | |
| Domain | GS | 7.21e-04 | 7 | 111 | 2 | PS51256 | |
| Domain | TGF_beta_GS | 7.21e-04 | 7 | 111 | 2 | PF08515 | |
| Domain | HTH_LA | 7.21e-04 | 7 | 111 | 2 | PS50961 | |
| Domain | GS | 7.21e-04 | 7 | 111 | 2 | SM00467 | |
| Domain | La | 7.21e-04 | 7 | 111 | 2 | PF05383 | |
| Domain | Lupus_La_RNA-bd | 7.21e-04 | 7 | 111 | 2 | IPR006630 | |
| Domain | zf-C2H2 | ZNF132 ZNF560 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 JAZF1 ZNF75D | 8.51e-04 | 693 | 111 | 12 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF132 ZNF560 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 JAZF1 ZNF75D | 8.62e-04 | 694 | 111 | 12 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF132 ZNF560 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 JAZF1 ZNF75D ZC3H7B | 8.85e-04 | 796 | 111 | 13 | IPR015880 |
| Domain | ARM-type_fold | 9.47e-04 | 339 | 111 | 8 | IPR016024 | |
| Domain | CPDc | 9.57e-04 | 8 | 111 | 2 | SM00577 | |
| Domain | VWA_3 | 9.57e-04 | 8 | 111 | 2 | PF13768 | |
| Domain | HATC_C_dom | 9.57e-04 | 8 | 111 | 2 | IPR008906 | |
| Domain | FCP1 | 9.57e-04 | 8 | 111 | 2 | PS50969 | |
| Domain | Dimer_Tnp_hAT | 9.57e-04 | 8 | 111 | 2 | PF05699 | |
| Domain | Znf_C2H2 | ZNF132 ZNF560 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 JAZF1 ZNF75D ZC3H7B | 9.80e-04 | 805 | 111 | 13 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF132 ZNF560 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 JAZF1 ZNF75D ZC3H7B | 1.01e-03 | 808 | 111 | 13 | SM00355 |
| Domain | NIF | 1.23e-03 | 9 | 111 | 2 | PF03031 | |
| Domain | FCP1_dom | 1.23e-03 | 9 | 111 | 2 | IPR004274 | |
| Domain | ANF_lig-bd_rcpt | 1.37e-03 | 37 | 111 | 3 | IPR001828 | |
| Domain | ANF_receptor | 1.37e-03 | 37 | 111 | 3 | PF01094 | |
| Domain | MIR | 1.53e-03 | 10 | 111 | 2 | PF02815 | |
| Domain | MIR_motif | 1.53e-03 | 10 | 111 | 2 | IPR016093 | |
| Domain | Activin_recp | 1.53e-03 | 10 | 111 | 2 | PF01064 | |
| Domain | MIR | 1.53e-03 | 10 | 111 | 2 | PS50919 | |
| Domain | MIR | 1.53e-03 | 10 | 111 | 2 | SM00472 | |
| Domain | Activin_recp | 1.53e-03 | 10 | 111 | 2 | IPR000472 | |
| Domain | Peripla_BP_I | 1.60e-03 | 39 | 111 | 3 | IPR028082 | |
| Domain | Tyr_kinase_cat_dom | 1.88e-03 | 88 | 111 | 4 | IPR020635 | |
| Domain | TyrKc | 1.88e-03 | 88 | 111 | 4 | SM00219 | |
| Domain | TGFB_receptor | 2.22e-03 | 12 | 111 | 2 | IPR000333 | |
| Domain | - | ZNF132 ZNF560 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF530 ZNF792 JAZF1 ZNF75D | 2.37e-03 | 679 | 111 | 11 | 3.30.160.60 |
| Domain | EF_HAND_2 | 2.58e-03 | 231 | 111 | 6 | PS50222 | |
| Domain | HTH_Tnp_Tc5 | 2.62e-03 | 13 | 111 | 2 | PF03221 | |
| Domain | EF_hand_dom | 2.64e-03 | 232 | 111 | 6 | IPR002048 | |
| Domain | PROTEIN_KINASE_TYR | 2.68e-03 | 97 | 111 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.68e-03 | 97 | 111 | 4 | IPR008266 | |
| Domain | TPR-like_helical_dom | 2.69e-03 | 233 | 111 | 6 | IPR011990 | |
| Domain | HEAT | 2.91e-03 | 48 | 111 | 3 | PF02985 | |
| Domain | EF_Hand_1_Ca_BS | 3.93e-03 | 175 | 111 | 5 | IPR018247 | |
| Domain | LIPOCALIN | 4.49e-03 | 17 | 111 | 2 | PS00213 | |
| Domain | Ion_trans_dom | 4.78e-03 | 114 | 111 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.78e-03 | 114 | 111 | 4 | PF00520 | |
| Domain | HEAT | 4.97e-03 | 58 | 111 | 3 | IPR000357 | |
| Domain | Kinase-like_dom | 5.03e-03 | 542 | 111 | 9 | IPR011009 | |
| Domain | Lipocalin | 5.03e-03 | 18 | 111 | 2 | IPR002345 | |
| Pubmed | Bone morphogenetic proteins, eye patterning, and retinocollicular map formation in the mouse. | 1.33e-07 | 4 | 113 | 3 | 18614674 | |
| Pubmed | 1.85e-06 | 8 | 113 | 3 | 16049014 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | POLR1A PRPF8 F5 ITPR3 BLMH EEF1G GTF3C1 COX5A YLPM1 MACF1 UTP20 PRKDC NOP2 FKBP4 | 6.18e-06 | 1024 | 113 | 14 | 24711643 |
| Pubmed | POLR1A LARP1 PRPF8 ITPR3 GTF3C1 YLPM1 MACF1 UTP20 PRKDC NOP2 FKBP4 | 9.68e-06 | 653 | 113 | 11 | 22586326 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 8068691 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9730621 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10850425 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28357470 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 38758791 | ||
| Pubmed | Serum starvation and growth factor receptor expression in vascular smooth muscle cells. | 1.05e-05 | 2 | 113 | 2 | 16407661 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15322331 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10607840 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 32764110 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20673479 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 29317596 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 33766086 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 29651654 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 31110197 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 3107886 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15102710 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12044155 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 35057644 | ||
| Pubmed | GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug Resistance. | 1.05e-05 | 2 | 113 | 2 | 28266043 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 31786200 | ||
| Pubmed | BMPR1A and BMPR1B Missense Mutations Cause Primary Ovarian Insufficiency. | 1.05e-05 | 2 | 113 | 2 | 31769494 | |
| Pubmed | Bmp in podocytes is essential for normal glomerular capillary formation. | 1.18e-05 | 14 | 113 | 3 | 18272846 | |
| Pubmed | EFCAB5 STIM2 CTDSPL2 LARP1 PRPF8 UBLCP1 PCF11 DES BMPR1A BMPR1B GTF3C1 SCN4A YLPM1 MACF1 PRKDC METTL25 | 1.76e-05 | 1442 | 113 | 16 | 35575683 | |
| Pubmed | 1.81e-05 | 16 | 113 | 3 | 24353058 | ||
| Pubmed | UNC13B GLIPR1 DCHS2 PDGFRB SYNM USP28 PRPF8 RYR3 YLPM1 MACF1 PRKDC KIFC3 GPRASP2 USP33 SNX5 | 1.83e-05 | 1285 | 113 | 15 | 35914814 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 2.20e-05 | 17 | 113 | 3 | 20639394 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | POGK RCN2 LARP1 PRPF8 PCF11 BLMH BMPR1A GTF3C1 INF2 YLPM1 PRKDC KIFC3 NOP2 KNL1 | 2.36e-05 | 1155 | 113 | 14 | 20360068 |
| Pubmed | STIM2 SYNM RCN2 NBN TRAPPC8 PRPF8 ITPR3 PCF11 COX5A INF2 ANKRD11 MACF1 NOP2 FKBP4 USP33 SNX5 | 2.55e-05 | 1487 | 113 | 16 | 33957083 | |
| Pubmed | 2.58e-05 | 106 | 113 | 5 | 19394292 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 9718984 | ||
| Pubmed | Possible pheromone-carrier function of two lipocalin proteins in the vomeronasal organ. | 3.13e-05 | 3 | 113 | 2 | 7813422 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 15265691 | ||
| Pubmed | Desmuslin, an intermediate filament protein that interacts with alpha -dystrobrevin and desmin. | 3.13e-05 | 3 | 113 | 2 | 11353857 | |
| Pubmed | Age-Associated Increase in BMP Signaling Inhibits Hippocampal Neurogenesis. | 3.13e-05 | 3 | 113 | 2 | 25538007 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 24048844 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 15673568 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 28912461 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 12051676 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 16432712 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 8707881 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 11714695 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 23831617 | ||
| Pubmed | The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development. | 3.13e-05 | 3 | 113 | 2 | 25413979 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 20363875 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 26592241 | ||
| Pubmed | BMP signaling specifies the development of a large and fast CNS synapse. | 3.13e-05 | 3 | 113 | 2 | 23708139 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 7750489 | ||
| Pubmed | BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. | 3.13e-05 | 3 | 113 | 2 | 20130193 | |
| Pubmed | Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours. | 3.13e-05 | 3 | 113 | 2 | 8605097 | |
| Pubmed | Biomechanical Properties of the Sarcolemma and Costameres of Skeletal Muscle Lacking Desmin. | 3.13e-05 | 3 | 113 | 2 | 34489727 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 21383159 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 17568996 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 35867797 | ||
| Pubmed | Role of type I receptors for anti-Müllerian hormone in the SMAT-1 Sertoli cell line. | 3.13e-05 | 3 | 113 | 2 | 15897891 | |
| Pubmed | Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. | 3.13e-05 | 3 | 113 | 2 | 26584636 | |
| Pubmed | Expression of bone morphogenetic protein receptors in the developing mouse metanephros. | 3.13e-05 | 3 | 113 | 2 | 11701996 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 33421565 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 25322858 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19726563 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 26285159 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 12181424 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 9480759 | ||
| Pubmed | Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. | 3.13e-05 | 3 | 113 | 2 | 8592941 | |
| Pubmed | ABCC1 CTDSPL2 RCN2 NBN PHF8 UBLCP1 ITPR3 PCF11 BLMH YLPM1 KIAA1328 FKBP4 KNL1 | 3.76e-05 | 1049 | 113 | 13 | 27880917 | |
| Pubmed | 6.09e-05 | 660 | 113 | 10 | 32780723 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 22100703 | ||
| Pubmed | Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells. | 6.25e-05 | 4 | 113 | 2 | 21152263 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 22293501 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 19596051 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 22971142 | ||
| Pubmed | RIM proteins activate vesicle priming by reversing autoinhibitory homodimerization of Munc13. | 6.25e-05 | 4 | 113 | 2 | 21262469 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 11401330 | ||
| Pubmed | HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression. | 6.25e-05 | 4 | 113 | 2 | 24904118 | |
| Pubmed | LTP of inhibition at PV interneuron output synapses requires developmental BMP signaling. | 6.25e-05 | 4 | 113 | 2 | 32572071 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 17913790 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 12644700 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 11282024 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 20587070 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 15235019 | ||
| Pubmed | A GDF5 point mutation strikes twice--causing BDA1 and SYNS2. | 6.25e-05 | 4 | 113 | 2 | 24098149 | |
| Pubmed | An increase in expression of the lipocalin 24p3 is found in mouse uterus coincident with birth. | 6.25e-05 | 4 | 113 | 2 | 7544071 | |
| Pubmed | The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling. | 6.25e-05 | 4 | 113 | 2 | 26701726 | |
| Pubmed | Chromosomal localization of three human genes encoding bone morphogenetic protein receptors. | 6.25e-05 | 4 | 113 | 2 | 10051328 | |
| Pubmed | Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs. | 6.25e-05 | 4 | 113 | 2 | 36309015 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 8605036 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 10375497 | ||
| Pubmed | Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. | 6.25e-05 | 4 | 113 | 2 | 19362533 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 10712517 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 8699248 | ||
| Pubmed | MDC1 regulates DNA-PK autophosphorylation in response to DNA damage. | 6.25e-05 | 4 | 113 | 2 | 15377652 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 19327734 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 21317933 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 9768843 | ||
| Pubmed | Regulation of RNA polymerase III transcription by Maf1 in mammalian cells. | 6.25e-05 | 4 | 113 | 2 | 18377933 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ABCC1 CTDSPL2 NBN PHF8 PRPF8 ITPR3 GTF3C1 COX5A YLPM1 ANKRD11 JAZF1 UTP20 PRKDC NOP2 | 8.04e-05 | 1294 | 113 | 14 | 30804502 |
| Pubmed | The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage. | 8.22e-05 | 26 | 113 | 3 | 31311865 | |
| Cytoband | 19q13.43 | 2.60e-06 | 87 | 113 | 5 | 19q13.43 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF132 ZNF560 ZNF862 ZNF772 ZNF551 ZNF557 ZNF773 ZNF547 ZNF713 ZNF530 ZNF792 JAZF1 ZNF75D | 4.22e-05 | 718 | 88 | 13 | 28 |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 4.84e-04 | 7 | 88 | 2 | 625 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 4.84e-04 | 7 | 88 | 2 | 345 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 4.84e-04 | 7 | 88 | 2 | 1201 | |
| GeneFamily | CTD family phosphatases | 6.43e-04 | 8 | 88 | 2 | 1041 | |
| GeneFamily | EF-hand domain containing | 7.00e-04 | 219 | 88 | 6 | 863 | |
| GeneFamily | Lipocalins | 3.80e-03 | 19 | 88 | 2 | 631 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.80e-03 | 19 | 88 | 2 | 563 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 6.99e-07 | 196 | 113 | 7 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.50e-06 | 168 | 113 | 6 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.88e-06 | 176 | 113 | 6 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.07e-06 | 177 | 113 | 6 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-06 | 177 | 113 | 6 | d731400997afea379f47ae8aa0f82802962b0861 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 6.68e-06 | 180 | 113 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.90e-06 | 181 | 113 | 6 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.12e-06 | 182 | 113 | 6 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.58e-06 | 184 | 113 | 6 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.31e-06 | 187 | 113 | 6 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.83e-06 | 189 | 113 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-06 | 190 | 113 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 9.66e-06 | 192 | 113 | 6 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.66e-06 | 192 | 113 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.95e-06 | 193 | 113 | 6 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 194 | 113 | 6 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CTL|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.09e-05 | 196 | 113 | 6 | ad9b0651cb2a15b750e453b2dcf782bca08b4fe7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 196 | 113 | 6 | c390ef0adff35111989a30dff86b7c5db1a89873 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 196 | 113 | 6 | 2f76f050083483f0880639e6c34ff349caac3503 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 197 | 113 | 6 | 01249bd485a3734de87ae6ed9c749597f39c6335 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-05 | 197 | 113 | 6 | febafd8f0f5bb9a09f496f240e6b6b5e9275669b | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-05 | 197 | 113 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 115 | 113 | 5 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 115 | 113 | 5 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 115 | 113 | 5 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 198 | 113 | 6 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | cellseq-Mesenchymal-Myocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-05 | 199 | 113 | 6 | 20e62a7029fa0d214244cdf2a481fc5d78290438 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 199 | 113 | 6 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 199 | 113 | 6 | 8ff0fdcbe9661b013913731ec8b53d84836ca865 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 199 | 113 | 6 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.18e-05 | 199 | 113 | 6 | c8bc05dece8b8a87d4a7a3e8112b924e15217de1 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-05 | 199 | 113 | 6 | 78b245d40c1e169ff2d26907b63d732e34529c5f | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.18e-05 | 199 | 113 | 6 | 8e1e95c3a4b856415af208be6ad977e575bac189 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.22e-05 | 200 | 113 | 6 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.22e-05 | 200 | 113 | 6 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.22e-05 | 200 | 113 | 6 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-05 | 200 | 113 | 6 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-05 | 200 | 113 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.22e-05 | 200 | 113 | 6 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.22e-05 | 200 | 113 | 6 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.22e-05 | 200 | 113 | 6 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-05 | 200 | 113 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.91e-05 | 140 | 113 | 5 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.56e-05 | 146 | 113 | 5 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 4.05e-05 | 150 | 113 | 5 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.18e-05 | 158 | 113 | 5 | 9e0589f770920f8ac41cfe5cd0a29e9e7a04a308 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.37e-05 | 165 | 113 | 5 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.33e-05 | 170 | 113 | 5 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-05 | 170 | 113 | 5 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-05 | 172 | 113 | 5 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-05 | 172 | 113 | 5 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.96e-05 | 173 | 113 | 5 | 2cba41c3d9d3076f703115d19729073a3ac3feb6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.96e-05 | 173 | 113 | 5 | 11d69a4ab4a87b8820cd3bd204de8c4124450a90 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 8.40e-05 | 175 | 113 | 5 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-05 | 175 | 113 | 5 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-05 | 175 | 113 | 5 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-05 | 177 | 113 | 5 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-05 | 177 | 113 | 5 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.87e-05 | 177 | 113 | 5 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.10e-05 | 178 | 113 | 5 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | COPD-Stromal-SMC|COPD / Disease state, Lineage and Cell class | 9.35e-05 | 179 | 113 | 5 | 5c705627bd13a5b2c7b0062fb3d94e4eb1589327 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.35e-05 | 179 | 113 | 5 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | COPD-Stromal-SMC|World / Disease state, Lineage and Cell class | 9.35e-05 | 179 | 113 | 5 | b2709537ec1b46457ab85261f4cdd354e60a8b29 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.60e-05 | 180 | 113 | 5 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.85e-05 | 181 | 113 | 5 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.85e-05 | 181 | 113 | 5 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 9.85e-05 | 181 | 113 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 183 | 113 | 5 | 983ca1342ddd365e1f1df32a456394b002b10e41 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 183 | 113 | 5 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 183 | 113 | 5 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 183 | 113 | 5 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 183 | 113 | 5 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 184 | 113 | 5 | 7d9294e5a55964903feda135e5bea0338824ed83 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 184 | 113 | 5 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 184 | 113 | 5 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 184 | 113 | 5 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-04 | 185 | 113 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.09e-04 | 185 | 113 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 185 | 113 | 5 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 185 | 113 | 5 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 186 | 113 | 5 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.15e-04 | 187 | 113 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.15e-04 | 187 | 113 | 5 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 187 | 113 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-04 | 187 | 113 | 5 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 1.18e-04 | 188 | 113 | 5 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 188 | 113 | 5 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.18e-04 | 188 | 113 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 188 | 113 | 5 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 188 | 113 | 5 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-04 | 188 | 113 | 5 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 1.18e-04 | 188 | 113 | 5 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-04 | 188 | 113 | 5 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.21e-04 | 189 | 113 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 191 | 113 | 5 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 191 | 113 | 5 | 5d6ef70cc15ec5e983a953e547e40f9c06e355fb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 113 | 5 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 191 | 113 | 5 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 113 | 5 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 192 | 113 | 5 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| Drug | lamotrigine | UGT1A5 GRIN2C GRIN2D RYR3 ITPR3 UGT1A3 CACNA2D4 SCN4A CACNA2D3 | 6.47e-09 | 116 | 113 | 9 | CID000003878 |
| Drug | gabapentin | GABRG3 GRID1 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 SCN4A CACNA2D3 GABRA3 | 1.25e-08 | 169 | 113 | 10 | CID000003446 |
| Drug | riluzole | GABRG3 GRID1 GRIN2C GRIN2D RYR3 ITPR3 CACNA2D4 SCN4A CACNA2D3 GABRA3 | 1.65e-08 | 174 | 113 | 10 | CID000005070 |
| Drug | baclofen | GABRG3 GRIN2C GRIN2D RYR3 ITPR3 BLMH CACNA2D4 CACNA2D3 GABRA3 | 4.80e-07 | 191 | 113 | 9 | CID000002284 |
| Drug | propofol | 5.11e-06 | 191 | 113 | 8 | CID000004943 | |
| Drug | ketamine | 6.49e-06 | 262 | 113 | 9 | CID000003821 | |
| Drug | nimodipine | 8.08e-06 | 145 | 113 | 7 | CID000004497 | |
| Drug | H-Ni | 1.07e-05 | 28 | 113 | 4 | CID000445665 | |
| Drug | loperamide | 1.41e-05 | 105 | 113 | 6 | CID000003954 | |
| Drug | AC1L9E0Q | 1.43e-05 | 30 | 113 | 4 | CID000443095 | |
| Drug | indole-2-carboxylic acid | 1.86e-05 | 32 | 113 | 4 | CID000072899 | |
| Drug | EAB 515 | 1.91e-05 | 11 | 113 | 3 | CID000159489 | |
| Drug | homocysteic acid | 1.93e-05 | 66 | 113 | 5 | CID000092117 | |
| Drug | gallopamil | 2.08e-05 | 67 | 113 | 5 | CID000001234 | |
| Drug | CNS 1145 | 2.11e-05 | 33 | 113 | 4 | CID000190902 | |
| Drug | IHC-64 | 2.11e-05 | 33 | 113 | 4 | CID000162753 | |
| Drug | AC1L2AC7 | 2.40e-05 | 69 | 113 | 5 | CID000068733 | |
| Drug | nitrosamine | 2.58e-05 | 70 | 113 | 5 | CID000037183 | |
| Drug | felbamate | 2.58e-05 | 70 | 113 | 5 | CID000003331 | |
| Drug | fluo-3 | 3.31e-05 | 122 | 113 | 6 | CID000104978 | |
| Drug | NSC7524 | 3.52e-05 | 182 | 113 | 7 | CID000005657 | |
| Drug | 2-amino-3-phosphonopropionic acid | 3.84e-05 | 76 | 113 | 5 | CID000003857 | |
| Drug | DHPN | 4.14e-05 | 39 | 113 | 4 | CID000040828 | |
| Drug | harmol | 4.58e-05 | 40 | 113 | 4 | CID000068094 | |
| Drug | DE gel | 8.04e-05 | 143 | 113 | 6 | CID000008146 | |
| Drug | NBQX | 8.65e-05 | 90 | 113 | 5 | CID003272523 | |
| Drug | Dantrolene-13C3 | 8.68e-05 | 145 | 113 | 6 | CID000002951 | |
| Disease | odorant-binding protein 2b measurement | 1.39e-04 | 5 | 111 | 2 | EFO_0801859 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 2.08e-04 | 6 | 111 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | amino acid measurement | 2.47e-04 | 678 | 111 | 10 | EFO_0005134 | |
| Disease | epilepsy (implicated_via_orthology) | 3.87e-04 | 163 | 111 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | X-11793--oxidized bilirubin measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0021260 | |
| Disease | Succinimide measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0022118 | |
| Disease | X-11530 measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0800692 | |
| Disease | X-24849 measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0802740 | |
| Disease | X-16946 measurement | 3.87e-04 | 8 | 111 | 2 | EFO_0800766 | |
| Disease | X-11442 measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 4.96e-04 | 9 | 111 | 2 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 6.19e-04 | 10 | 111 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 6.19e-04 | 10 | 111 | 2 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 6.19e-04 | 10 | 111 | 2 | EFO_0802185 | |
| Disease | X-23974 measurement | 6.19e-04 | 10 | 111 | 2 | EFO_0800867 | |
| Disease | Gastric Adenocarcinoma | 6.55e-04 | 45 | 111 | 3 | C0278701 | |
| Disease | histidine betaine (hercynine) measurement | 7.54e-04 | 11 | 111 | 2 | EFO_0800972 | |
| Disease | X-21796 measurement | 7.54e-04 | 11 | 111 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 7.54e-04 | 11 | 111 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 7.54e-04 | 11 | 111 | 2 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 9.03e-04 | 12 | 111 | 2 | EFO_0800079 | |
| Disease | biliverdin measurement | 9.03e-04 | 12 | 111 | 2 | EFO_0021033 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.06e-03 | 13 | 111 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | retinol dehydrogenase 16 measurement | 1.06e-03 | 13 | 111 | 2 | EFO_0802007 | |
| Disease | Kuhnt-Junius degeneration (is_marker_for) | 1.24e-03 | 14 | 111 | 2 | DOID:10873 (is_marker_for) | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 1.44e-03 | 59 | 111 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 1.63e-03 | 16 | 111 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | Eye Abnormalities | 1.84e-03 | 17 | 111 | 2 | C0015393 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.84e-03 | 17 | 111 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 2.06e-03 | 18 | 111 | 2 | EFO_0801382 | |
| Disease | Prostate cancer, familial | 2.27e-03 | 69 | 111 | 3 | C2931456 | |
| Disease | Congenital hernia of foramen of Morgagni | 2.30e-03 | 19 | 111 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 2.30e-03 | 19 | 111 | 2 | C0265700 | |
| Disease | Fetal Growth Retardation | 2.55e-03 | 20 | 111 | 2 | C0015934 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.64e-03 | 152 | 111 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Congenital diaphragmatic hernia | 2.81e-03 | 21 | 111 | 2 | C0235833 | |
| Disease | tissue factor measurement | 2.81e-03 | 21 | 111 | 2 | EFO_0010623 | |
| Disease | peak expiratory flow | 2.81e-03 | 498 | 111 | 7 | EFO_0009718 | |
| Disease | Lung diseases | 3.21e-03 | 78 | 111 | 3 | C0024115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLTTYAISWTQDEFD | 76 | P35503 | |
| FSSQIYDEEATWELR | 116 | Q6UXE8 | |
| KSWYIADIFTDESED | 1111 | Q6UB99 | |
| SAHAEATYEEDWEVF | 241 | Q05D32 | |
| AGWEESETETYTEVV | 1076 | Q8IUX7 | |
| CETEASEQWDYVLVA | 26 | A1A5B4 | |
| TEEASWFRETEIYQT | 236 | O00238 | |
| VSETLQEIYSSEWDG | 81 | Q9UBW5 | |
| EEDSRQEWTFTLYDF | 131 | Q969G9 | |
| WLDTFVSSYEQFLDV | 26 | Q6ZS30 | |
| FVEYDKNSDDTVTWD | 106 | Q14257 | |
| EYLSIEYSEEEVWLT | 681 | Q14573 | |
| LSTTEWNDETLYQEF | 66 | Q13231 | |
| EEFYVDLETKETVWQ | 56 | P01906 | |
| NTFTAWSDEESDYEI | 621 | Q6PKG0 | |
| SSAITNWYDEIQDYD | 111 | P48060 | |
| SEFSNWYTEALQDEE | 301 | Q96LZ2 | |
| VYSWRDDEFDEASSQ | 266 | A5PLN7 | |
| SWRYEETSENEAVAE | 841 | Q8IX03 | |
| VDTVEDFWALYSHIQ | 91 | A6NMX2 | |
| AHTVDFYTESVWEEL | 36 | Q8N6Q8 | |
| EEHDSYSDQVWSIDE | 3061 | Q2LD37 | |
| EVDYEESDSDESWTT | 136 | Q86VZ6 | |
| IWYSIGDYEVIDEVT | 366 | Q8NCM2 | |
| FSAADVYVPDEWEVA | 981 | P08069 | |
| DYTSFNTVDEWLEAI | 911 | P29323 | |
| DVVEWSDDQAVFTFV | 2136 | Q8NG31 | |
| EYTIDVFFRQTWHDE | 111 | P34903 | |
| EVAIYFSDEEWEVLT | 51 | Q9P215 | |
| LSFTLEEEDITGTWY | 16 | Q9NY56 | |
| WSRDFSDEEQSVVYV | 16 | Q86T90 | |
| SSWYVDASDVLTTED | 1076 | Q27J81 | |
| YEQAADAELAWVAET | 5676 | Q9UPN3 | |
| FWEESSYEELDDVTS | 806 | Q5TIA1 | |
| ENIEVYHEFWFEEAT | 526 | O43422 | |
| SWTFEHLVYQVEVSE | 1081 | Q6V1P9 | |
| YSLTDWIEFEEIADL | 1386 | O94913 | |
| LSFTLEEEDITGTWY | 16 | Q9NPH6 | |
| RSWEQTYEEEIFLSS | 701 | A4FU69 | |
| NYVARVDSLETEEWF | 131 | P08631 | |
| IEEIAYNAISFTWDI | 351 | Q9NZI5 | |
| NVATEETVFYALESW | 191 | Q9NXS3 | |
| IYGTNSEWETFDVTD | 191 | O95393 | |
| EYQIDIFFAQTWTDS | 91 | Q99928 | |
| QEHDVVWTEAYIDST | 446 | Q8IZS8 | |
| YNSVDLSEVEWEDQA | 586 | Q7Z3S7 | |
| YETIAAKNISEAEEW | 281 | P17661 | |
| EWDAVEFVIHSYRET | 911 | Q8WXX0 | |
| TEEASWFRETEIYQT | 266 | P36894 | |
| TDEWFSEYVYEVVVD | 411 | Q13867 | |
| WDVAVVEYAALTDDD | 741 | Q9ULK0 | |
| LYELWEEYETQSSAE | 121 | Q7Z4H3 | |
| VTTDADQDYDYLSDW | 756 | P55285 | |
| SEETQTLVREYFSWE | 406 | P26641 | |
| IVSWLEYESSFSNEE | 296 | Q02790 | |
| AWFTEEDLDLVTLYF | 181 | Q6UWV6 | |
| AEVLFYWTDQEFEES | 11 | Q92902 | |
| QETDEEFDARWVTYF | 46 | P20674 | |
| TFEESVSNYSEWAVF | 21 | Q8IZU8 | |
| VSNYSEWAVFTDDID | 26 | Q8IZU8 | |
| AQLTDDSDIYWTAEV | 581 | P22223 | |
| NTFTDWSDNDSDYEI | 426 | Q659C4 | |
| EEESQLETNVTYWEE | 471 | P09619 | |
| LETNVTYWEEEQEFE | 476 | P09619 | |
| TYWEEEQEFEVVSTL | 481 | P09619 | |
| FSQYSDEEVWTSLEL | 1391 | P33527 | |
| DIFLDWESYQFRTEE | 1161 | O75691 | |
| WESYQFRTEEIDAVF | 1166 | O75691 | |
| ETFETKVDDYSQEWA | 1161 | O95602 | |
| ATNDTFDWDAYISDE | 331 | P35499 | |
| LFADYLQSEVWDSEE | 666 | Q3MII6 | |
| VAESWRETVQLYEDE | 191 | O15061 | |
| EEESTIRYSWQDEIV | 856 | O15061 | |
| AEEISWDYSEFVQRE | 1586 | P12259 | |
| TTYVADTESEQADTW | 361 | O60934 | |
| YESIEYWNTSVQEDV | 561 | Q96NR3 | |
| FSEVQEKASDWEYTI | 556 | Q9BVG8 | |
| WEYTITVSAAEIYNE | 566 | Q9BVG8 | |
| FESESEDEFYKQSWV | 326 | Q96D09 | |
| WYSDQDFESEFVEVL | 166 | Q9H1D9 | |
| FYEDTNSWIEDTEFL | 721 | P14410 | |
| TCSITVEENEWVVDY | 516 | P46087 | |
| KVVDWEESTEVTLYF | 751 | Q9NRP7 | |
| TDISFYNWDADIAVS | 156 | Q6V702 | |
| VEEQYEESFWICVAS | 181 | A0PK11 | |
| ESEFIDSQRVWAEYA | 1376 | Q6P2Q9 | |
| VSSLDWQVYFAEEPE | 521 | Q2L4Q9 | |
| YDTKDASVTDWVINE | 886 | Q9NR97 | |
| EDVAVYFSQEEWELL | 41 | P52740 | |
| LTEAEWEDLTQQYYS | 296 | A6PVC2 | |
| EEEAIYFSAEKQWEV | 576 | Q9P246 | |
| WIETEEYSFEEKLVQ | 3516 | Q15413 | |
| FEDNTLTERFWESYI | 81 | O14669 | |
| FEDVAIYFSQEEWEL | 31 | Q7Z340 | |
| TLTTYAISWTQDEFD | 76 | P35504 | |
| DDAWKVYFDETAQEI | 771 | O14795 | |
| INSITDIYETEEEGW | 271 | Q5VVX9 | |
| DFVWLHDTLIETTDY | 71 | Q9Y5X3 | |
| YNDISVTESSWEEVE | 616 | Q96RU2 | |
| VTESSWEEVERDSYG | 621 | Q96RU2 | |
| TSAVEQERWDEDSFY | 1566 | P49750 | |
| LSECEFQEYTIDSDW | 2581 | P78527 | |
| VTFDDITVYLLQEEW | 11 | O60290 | |
| TFEDVAVYFSQEEWR | 16 | Q6PK81 | |
| TFEDVAVYFSEEEWQ | 236 | P51815 | |
| VVFEDVAIYFSQEEW | 11 | Q8IVP9 | |
| FEDVTIYFSQEEWVL | 16 | Q3KQV3 | |
| TSAYEDYDIVIWSAT | 171 | Q8WVY7 | |
| EYDSESSQQWRELEE | 701 | Q9Y2L5 | |
| YWRTESEEEEENASL | 821 | Q9UPP1 | |
| FEDVAIYFSQEEWEL | 16 | Q6P9A1 | |
| DVAVDFTREEWDQLY | 36 | Q8N859 | |
| TWEAEVELATETVYV | 866 | Q12789 | |
| VELATETVYVDDASW | 871 | Q12789 | |
| VTFEDVAVEFTQEEW | 36 | Q8N988 | |
| EDSNVWHDISDFLVY | 191 | Q9Y6I8 | |
| DVFVYFSQEEWVLLD | 31 | Q68DY9 | |
| WYEFDDQSVTEVSES | 686 | Q8TEY7 | |
| TFDSVAVEFTQEEWT | 111 | Q96MR9 | |
| TFAYHQEEIDVWTEE | 501 | Q9UGR2 | |
| VLEEYDWSAFAVITS | 156 | Q14957 | |
| FEVLEEYDWTSFVAV | 176 | O15399 |